Similar articles

• [Treatment of hepatitis C virus-related cirrhosis].

  Bronowicki JP. Bronowicki JP. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B220-4. Gastroenterol Clin Biol. 2002. PMID: 12180292 Review. French. No abstract available.
• Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.

  Shindo M, Ken A, Okuno T. Shindo M, et al. Cancer. 1999 May 1;85(9):1943-50. Cancer. 1999. PMID: 10223234
• Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.

  Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U. Testino G, et al. Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8. Hepatogastroenterology. 2002. PMID: 12397752
• [Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related chronic hepatitis and cirrhosis].

  Kasahara A, Hiramatsu N. Kasahara A, et al. Nihon Rinsho. 2011 May;69 Suppl 4:314-8. Nihon Rinsho. 2011. PMID: 22096937 Review. Japanese. No abstract available.
• [Histological findings in the liver in patients with chronic hepatitis C].

  Takase K, Shiraki K. Takase K, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):434-8. Nihon Rinsho. 2004. PMID: 15359838 Review. Japanese. No abstract available.